Company

Simcere Zaiming

Pharmaceutical Manufacturing Cn 35 employees ABBV

Employees: 35
Contacts: 2
Emails: 2

LinkedIn Crunchbase

Simcere Zaiming Overview

Headquarters: Cn
Industry: Pharmaceutical Manufacturing
Employees: 35
Founded: 2023
Stock Symbol: ABBV
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

About Simcere Zaiming

Simcere Zaiming is a pharmaceutical company specializing in oncology, and a subsidiary of Simcere Pharmaceutical Group Limited, that focuses on the R&D, production and commercialization of innovative cancer therapeutics. The company was formed in 2023 and is committed to solving unmet clinical needs for cancer patients in China and around the world by developing breakthrough treatments. Simcere Zaiming has an innovative R&D pipeline with differentiated clinical value, among which 15 assets are currently in clinical trials. In addition to the company’s R&D portfolio, Simcere Zaiming is marketing three innovative drugs, COSELA®, Endostar®, and Envafolimab®. By collaborating with partners globally, Simcere Zaiming strives to bring potentially new innovative therapeutics to cancer patients worldwide.

Simcere Zaiming Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage

Simcere Zaiming Org Chart

Sample employees and titles

Name	Title	Location	Contact
Nikolaos Patsoukis	Principal Scientist at Simcere Zaiming	Boston, Massachusetts, United States	Email
Fayong "Frank" Luo	Director of Business Development		View
Pankaj Seth	Executive Director, Simcere Pharmaceutical Group, U.s	Cambridge, Massachusetts, United States	Email